Immunomodulation of Potent Antioxidant Agents: Preclinical Study to Clinical Application in Multiple Sclerosis

QR Code

Immunomodulation of Potent Antioxidant Agents: Preclinical Study to Clinical Application in Multiple Sclerosis

None

Saved in:

Bibliographic Details
Main Authors:	Fan, Shyi-Jou Chen Hueng-Chuen, Sytwu, Huey-Kang
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27663
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Ivy Leaf Dry Extract EA 575<sup>®</sup> Is a Potent Immunomodulator Acting on Dendritic Cells
by: Miodrag Čolić, et al.
Published: (2025-06-01)

Neuroimaging in Multiple Sclerosis
by: Andreadou, Elisabeth
Published: (2012)

Paramyxoviruses and Multiple Sclerosis
by: Baghdad Science Journal
Published: (2012-09-01)

Ageing and multiple sclerosis
by: Julija Isačenko, et al.
Published: (2024-12-01)

EFFICACY OF IMMUNOMODULATORS AND ANTIOXIDANTS IN THE CORRECTION OF IMPAIRED IMMUNE STATUS PARAMETERS IN PATIENTS WITH ADENOMYOSIS
by: O. Yu. Ivanova, et al.
Published: (2021-10-01)

Clinical and immunological features of the pediatric multiple sclerosis
by: V. M. Lebedev, et al.
Published: (2025-06-01)

Multiple sclerosis and pregnancy. Impact of multiple sclerosis disease-modifying therapy on the health of newborns
by: T. I. Yakushina
Published: (2021-02-01)

Multiple Sclerosis and Celiac Disease
by: Hernández-Lahoz, Carlos, et al.
Published: (2012)

Pathogenetic therapy of multiple sclerosis
by: N. V. Komissarova, et al.
Published: (2023-09-01)

ERECTILE DYSFUNCTION IN MULTIPLE SCLEROSIS
by: Константин Александрович Бурдин, et al.
Published: (2017-09-01)

Multiple sclerosis: 2024 update
by: Luisa Klotz, et al.
Published: (2025-07-01)

Comparative analysis of brivaracetam and levetiracetam in epilepsy treatment
by: Ming-Yuan Hsu, et al.
Published: (2025-01-01)

Essential Oils of Umbelliferae (Apiaceae) Family Taxa as Emerging Potent Agents for Mosquito Control
by: Evergetis, Epameinondas, et al.
Published: (2012)

INFLUENCE OF IMMUNOMODULATING AGENTS IMMUNOVAK VP-4 AND PROFETAL ON FUNCTIONAL ACTIVITY OF MONONUCLEAR LEUKOCYTES
by: E. A. Lebedinskaya, et al.
Published: (2014-07-01)

Clinical and epidemiological peculiarities of multiple sclerosis in rostov region
by: Z. A. Goncharova
Published: (2010-03-01)

EUDOGENOUS AND EXOGENOUS IMMUNOMODULATORS
by: Editorial article
Published: (2014-07-01)

EUDOGENOUS AND EXOGENOUS IMMUNOMODULATORS
by: Editorial article
Published: (2014-07-01)

EUDOGENOUS AND EXOGENOUS IMMUNOMODULATORS
by: Editorial article
Published: (2014-07-01)

EUDOGENOUS AND EXOGENOUS IMMUNOMODULATORS
by: Editorial article
Published: (2014-07-01)

EUDOGENOUS AND EXOGENOUS IMMUNOMODULATORS
by: Editorial article
Published: (2014-07-01)

Bowel Dysfunction in Persons with Multiple Sclerosis
by: Gulick, Elsie E., et al.
Published: (2012)

Cognitive disturbances in patients with multiple sclerosis
by: V. M. Alifirova, et al.
Published: (2008-09-01)

Investigation of the bone density in multiple sclerosis
by: O. S. Dranichnikova, et al.
Published: (2008-06-01)

Neurorehabilitation in complex treatment of multiple sclerosis
by: I. A. Rybak, et al.
Published: (2008-12-01)

Apoptosis cells in patients with multiple sclerosis
by: S. A. Vostryakova, et al.
Published: (2008-12-01)

Neuritis retrobulbaris of multiple sclerosis patients
by: Yu. N. Ignatova, et al.
Published: (2009-06-01)

Autoimmune eye diseases in multiple sclerosis
by: M.L. Martínez Ginés, et al.
Published: (2025-07-01)

Autoimmune skin diseases in multiple sclerosis
by: M. Roncero Riesco, et al.
Published: (2025-07-01)

Inflammatory bowel disease and multiple sclerosis
by: M. Dominguez-Gallego, et al.
Published: (2025-07-01)

Other autoimmune diseases and multiple sclerosis
by: S. Martínez-Yélamos, et al.
Published: (2025-07-01)

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury
by: Yong Chen, et al.
Published: (2025-07-01)

STUDYING OF APPLICATION IMMUNOMODULATOR «GALAVIT» AT EXPERIMENTAL ATHEROSCLEROSIS
by: E. P. Turmova, et al.
Published: (2012-05-01)

Pharmacoeconomic Evaluation of Using One-Molar Gadolinium-Based Magnetic Resonance Contrast Agent Compared to Half-Molar Agents for the Diagnosis of Multiple Sclerosis
by: A. A. Alikhanov, et al.
Published: (2020-11-01)

Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agents
by: Jason H. Gill, et al.
Published: (2025-12-01)

Systematic review of clinical practice guidelines related to multiple sclerosis.
by: Jia Guo, et al.
Published: (2014-01-01)

Anacyphrethines A and B as potent analgesics: Multiple ion channel inhibitors with an unprecedented chemical architecture
by: Hui Chen, et al.
Published: (2025-07-01)

THE STUDY OF IMMUNOMODULATING PROPERTIES OF THE VITANAM
by: V. S. Orlova, et al.
Published: (2019-01-01)

IMMUNOMODULATORS OF ENDOGENOUS AND EXOGENOUS NATURE
by: Article Editorial
Published: (2015-06-01)

Immunomodulators in Therapy of Respiratory Infections
by: V. A. Isakov, et al.
Published: (2020-05-01)

Molecular action mechanisms of the immunomodulators
by: Belteghi, C.
Published: (2008-06-01)